MIMEDX GROUP, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $418.6 | $348.9 | $321.5 | $267.8 | $242.0 |
| Operating income | $63.9 | $58.9 | $37.1 | -$14.7 | -$7.1 |
| Net income | $48.6 | $42.4 | $58.2 | -$30.2 | -$10.3 |
| Cash Flow Statement | |||||
| Free cash flow | $74.0 | $66.2 | $24.8 | -$19.4 | -$5.2 |
| Share repurchases | $0.0 | $0.0 | $9.5 | $0.0 | $0.0 |
Shares outstanding 145.8M · Free float 67.9%
Annual filing data through FY ended December 31, 2025; float as of September 28, 2026.